ENGN vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 02, 2026

ENGN

57.1
AI Score
VS
ENGN Wins

CBIO

54.5
AI Score

Investment Advisor Scores

ENGN

57score
Recommendation
HOLD

CBIO

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ENGN CBIO Winner
Net Income -59.98M 153,942 CBIO
Operating Income -63.15M -152.63M ENGN
ROE -23.5% 0.1% CBIO
ROA -19.5% 0.1% CBIO
Total Assets 307.52M 240.29M ENGN
Cash 29.83M 213.19M CBIO
Current Ratio 12.57 6.56 ENGN
Free Cash Flow -59.65M -72.45M ENGN

Relative Price Performance (Last 90 Days)

ENGN 1M: -0.6% · 3M: -75.6% CBIO 1M: -13.0% · 3M: -17.7%

Current Technical Phase

ENGN

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -38.3%) with fading momentum, RSI 40

RSI (14): 40.2 · Price: $1.77

CBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.2%), weak momentum, RSI 41

RSI (14): 41.2 · Price: $14.87

Fundamentals Snapshot

Metric ENGN CBIO
Market Cap
Forward P/E -1.3 -5.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 1.0%
Operating Margin 0.0% -14.3%
EPS -2.18 -0.14
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ENGN is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.